- Home
- VSTS vs HRMY Comparison
VSTS vs HRMY Comparison
Compare VSTS & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VSTS
- HRMY
- Stock Information
- Founded
- VSTS 1936
- HRMY 2017
- Country
- VSTS United States
- HRMY United States
- Employees
- VSTS N/A
- HRMY N/A
- Industry
- VSTS
- HRMY Biotechnology: Pharmaceutical Preparations
- Sector
- VSTS
- HRMY Health Care
- Exchange
- VSTS Nasdaq
- HRMY Nasdaq
- Market Cap
- VSTS 763.0M
- HRMY 2.0B
- IPO Year
- VSTS N/A
- HRMY 2020
- Fundamental
- Price
- VSTS $6.15
- HRMY $32.16
- Analyst Decision
- VSTS Hold
- HRMY Strong Buy
- Analyst Count
- VSTS 4
- HRMY 9
- Target Price
- VSTS $11.75
- HRMY $54.22
- AVG Volume (30 Days)
- VSTS 2.9M
- HRMY 620.8K
- Earning Date
- VSTS 08-06-2025
- HRMY 08-05-2025
- Dividend Yield
- VSTS 1.71%
- HRMY N/A
- EPS Growth
- VSTS N/A
- HRMY 13.13
- EPS
- VSTS N/A
- HRMY 2.62
- Revenue
- VSTS $2,731,558,000.00
- HRMY $744,852,000.00
- Revenue This Year
- VSTS N/A
- HRMY $20.10
- Revenue Next Year
- VSTS $0.36
- HRMY $18.01
- P/E Ratio
- VSTS N/A
- HRMY $12.27
- Revenue Growth
- VSTS N/A
- HRMY 20.62
- 52 Week Low
- VSTS $5.20
- HRMY $26.47
- 52 Week High
- VSTS $17.83
- HRMY $41.61
- Technical
- Relative Strength Index (RSI)
- VSTS 48.94
- HRMY 43.25
- Support Level
- VSTS $5.56
- HRMY $31.70
- Resistance Level
- VSTS $6.26
- HRMY $33.69
- Average True Range (ATR)
- VSTS 0.26
- HRMY 0.89
- MACD
- VSTS 0.07
- HRMY -0.10
- Stochastic Oscillator
- VSTS 84.29
- HRMY 37.30
About VSTS Vestis Corporation
Vestis Corp is a provider of uniform rentals and workplace supplies across the United States and Canada. It provides uniforms, mats, towels, linens, restroom supplies, first-aid supplies, safety products, and other workplace supplies. The Company serves customers ranging from small, family-owned operations with a single location to large corporations and national franchises with multiple locations. The company operates in the United States and Canada as reportable segments. The company earns the majority of its revenue from the United States.
About HRMY Harmony Biosciences Holdings Inc.
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.